Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lava Therapeutics N.V. (LVTX)

Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lava Therapeutics N.V. YALELAAN 62 UTRECHT P7 3584 CM NLD

www.lavatherapeutics.com Employees: 35 P: 31-85-016-3100

Description:

LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy. LAVA Therapeutics B.V. is based in UTRECHT, The Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 38,532
Enterprise Value, $K -418
Shares Outstanding, K 25,350
Annual Sales, $ 6,770 K
Annual Net Income, $ -41,970 K
Last Quarter Sales, $ 6,990 K
Last Quarter Net Income, $ -550 K
EBIT, $ -31,670 K
EBITDA, $ -32,290 K
60-Month Beta 0.49
% of Insider Shareholders 0.79%
% of Institutional Shareholders 0.00%
Float, K 0
% Float 0.00%
Short Volume Ratio 0.30

Growth:

1-Year Return -0.67%
3-Year Return -78.04%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 08/20/24
Next Earnings Date 11/21/24 [--]
Earnings Per Share ttm -1.08
EPS Growth vs. Prev Qtr -1,450.00%
EPS Growth vs. Prev Year 35.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LVTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.53%
Return-on-Assets % -23.94%
Profit Margin % -619.94%
Debt/Equity 0.10
Price/Sales 5.40
Price/Cash Flow N/A
Price/Book 0.46
Book Value/Share 0.00
Interest Coverage -2.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar